Business Context and Reporting Period
This Form 8-K was filed by Zanite Acquisition Corp. on November 25, 2020, reporting events occurring on November 19, 2020. The supplied metadata identifies Eve Holding, Inc., but the filing itself identifies the registrant as Zanite Acquisition Corp.; no Eve Holding information appears in the filing.
Zanite completed its initial public offering and related private placement. The filing includes an audited balance sheet as of November 19, 2020 as Exhibit 99.1.
Key Financial Metrics
- IPO: 23,000,000 units sold at $10.00 per unit, generating $230.0 million in gross proceeds. The total includes 3,000,000 units issued upon full exercise of the underwriters’ over-allotment option.
- IPO securities: Each unit included one share of Class A common stock and one-half of one redeemable warrant. Each whole warrant is exercisable for one share at $11.50, subject to adjustment.
- Private placement: 9,650,000 warrants sold to Zanite Sponsor LLC at $1.00 per warrant, generating $9.65 million in gross proceeds.
- Trust account: $232.3 million was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company as trustee. This comprised $225.4 million of IPO proceeds, including $8.05 million of underwriters’ deferred discount, and $6.9 million of private-placement proceeds.
- Revenue, profit, cash flow, margins and debt: The filing text does not provide clear values for these metrics. It is an event report focused on the IPO and private placement.
Material Changes Versus Prior Comparable Period
No prior comparable financial period or operating results are presented. The material change reported is the completion of the IPO and private placement and the funding of the trust account.
Guidance, Outlook, Risks and Unusual Items
- The filing does not provide management guidance, operating forecasts or a business-combination target.
- The $8.05 million underwriters’ deferred discount is included in the reported IPO proceeds placed in the trust account.
- The warrants are redeemable or exercisable securities with an exercise price of $11.50 per share; the filing text does not provide further redemption terms or conditions.
- The filing does not describe specific contingencies, litigation or other unusual items beyond the IPO structure and private placement.
Facts Investors Should Verify
- Confirm that the relevant registrant is Zanite Acquisition Corp., not Eve Holding, Inc., based on the filing text.
- Review Exhibit 99.1 for the audited November 19, 2020 balance sheet and the precise accounting treatment of IPO costs, warrants and trust-account assets.
- Verify the amount and conditions of the $8.05 million deferred underwriting discount.
- Review the governing IPO and warrant documents for redemption rights, exercise adjustments and restrictions on use of trust-account funds.